ARA-290 vs KPV
Updated 9 sources
Key differences
- 1ARA-290 works through the innate repair receptor on nerves. KPV is a three-amino-acid anti-inflammatory fragment studied mostly in animals.
Side by side
Facts from each record, in the same words as their own pages.
| ARA-290 | KPV | |
|---|---|---|
| Category |
|
|
| Evidence |
|
|
| FDA status |
|
|
| WADA |
|
|
| Half-life |
|
|
| Routes |
|
|
| Forms |
|
|
| Reported doses |
|
|
| Most cited frequency |
|
|
| Vial sizes |
|
|
| Mixed vial keeps |
|
|
| Protocols on file |
|
|
Doses shown are what sources report, labelled by origin. Not medical advice.
Read each in full
Sources
9 sources, each checked by date. Record updated Oct 24, 2026. Numbers are restated in our own words and labelled by where they came from.
Clinical study2
- Collino M et al. 2015, Flipping the molecular switch for innate protection and repair of tissues, Pharmacol TherPubMed · checked Oct 24, 2026
- Thomas A et al. 2017, In vitro metabolites of selected peptides under 2 kDa prohibited in sports, Drug Test AnalPubMed · checked Oct 24, 2026
Regulatory4
- Orphan drug designation: cibinetide (ARA-290), neuropathic pain in sarcoidosisFDA · checked Oct 24, 2026
- Orphan drug designation: cibinetide (ARA-290), sarcoidosisFDA · checked Oct 24, 2026
- Bulk Drug Substances Nominated for Use in Compounding Under Section 503A (updated April 22, 2026)FDA (Internet Archive copy) · checked Oct 24, 2026
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety RisksFDA · checked Oct 24, 2026
Competitor guide3
- ARA-290 peptide protocol guidepeptidedosingprotocols.com · checked Oct 24, 2026
- KPV dosage chartpeptidedeck.com · checked Oct 23, 2026
- KPV protocolpeptidedosingprotocols.com · checked Oct 23, 2026